09:28 AM EST, 11/05/2024 (MT Newswires) -- NeoGenomics ( NEO ) reported Q3 adjusted earnings Tuesday of $0.05 per diluted share, compared with breakeven a year earlier.

Analysts polled by Capital IQ expected $0.01 per share.

Revenue for the quarter ended Sept. 30 was $167.8 million, up from $152 million a year earlier.

Analysts surveyed by Capital IQ expected $167 million.

NeoGenomics ( NEO ) said it now expects 2024 adjusted earnings of $0.08 to $0.10 per diluted share, up from its prior guidance of $0.02 to $0.07. Analysts expect $0.06.

The company continues to expect 2024 revenue of $655 million to $667 million. Analysts polled by Capital IQ expect $662 million.

Shares of the company were down 1% in recent premarket activity.

Price: 13.88, Change: -0.26, Percent Change: -1.84